The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
What Is Simeigelutai? UK Health Information
Simeigelutai is a prescription-only GLP-1 receptor agonist medication licensed for weight management in the UK. It works by mimicking a natural hormone that helps regulate appetite and food cravings. Like other GLP-1 medications such as Wegovy, simeigelutai may help you feel fuller after eating smaller meals and reduce overall food intake. It's administered as a once-weekly injection. This guide explains how it works, who may be eligible, what to expect, and how to access it through UK healthcare services. Always consult your GP or a qualified healthcare professional before considering any weight management medication.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Simeigelutai Works and What to Expect
Simeigelutai is a GLP-1 receptor agonist — it activates the GLP-1 hormone pathway in your body. This natural hormone is produced in your gut after eating and signals to your brain that you're full, helping you eat less and feel satisfied with smaller portions. Simeigelutai amplifies these effects, which may lead to reduced appetite and lower food cravings.
The medication is administered as a once-weekly injection, making it convenient to use alongside your daily routine. Treatment typically starts at a low dose and is gradually increased over several weeks to help your body adjust and minimise side effects. Like all GLP-1 medications, simeigelutai works best when combined with a reduced-calorie diet and increased physical activity — medication alone is not a substitute for lifestyle changes. Weight loss results vary significantly between individuals, and clinical trials have shown average weight loss of around 15–20% of body weight over several months, depending on the dose and individual response.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
UK Access, Eligibility, and Prescribing
In the UK, simeigelutai is available through NHS specialist weight management services (tier 3 and tier 4) or through private online prescribing. For NHS access, you'll typically need a referral from your GP to a specialist weight management service, though availability varies significantly by region and waiting times can be lengthy.
You may be eligible if you have a BMI of 30 kg/m² or above, or a BMI of 27–29.9 with at least one weight-related health condition such as type 2 diabetes, prediabetes, high blood pressure, or sleep apnoea. For adults of South Asian, Chinese, Black African, or Black Caribbean heritage, lower BMI thresholds may apply. A prescriber will assess your individual circumstances before prescribing. Always speak to your GP about whether this medication is suitable for you.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is simeigelutai the same as Wegovy or Mounjaro?
Simeigelutai is a GLP-1 medication, similar in mechanism to Wegovy (semaglutide). However, Mounjaro (tirzepatide) is a dual GIP/GLP-1 agonist, which is a different mechanism. All three are prescription-only weight management medications licensed in the UK, but they work slightly differently and have different dose schedules. Your prescriber will advise which is most suitable.
What are the main side effects of simeigelutai?
Common side effects include nausea, diarrhoea, constipation, and stomach pain, particularly when starting or increasing doses. These often improve over time as your body adjusts. Serious side effects are rare but may include severe stomach pain (possible pancreatitis) or gallbladder problems. Always report any concerning symptoms to your prescriber immediately.
How much weight can I expect to lose on simeigelutai?
Individual results vary significantly. Clinical trials have shown average weight loss of around 15–20% of body weight over several months, though some people may lose more or less. Weight loss depends on your starting weight, adherence to the medication, diet, exercise, and individual metabolic factors. Your GP can discuss realistic expectations based on your circumstances.
Can I get simeigelutai on the NHS?
Yes, simeigelutai may be available through NHS specialist weight management services (tier 3/4). Access requires referral from your GP and varies by region. Waiting times can be several months in some areas. Private online prescribing is also available in the UK following a clinical assessment, though this involves a cost.
How does simeigelutai compare to diet and exercise alone?
GLP-1 medications like simeigelutai work best alongside lifestyle changes — they're not replacements for diet and exercise. Research shows combining medication with calorie reduction and physical activity produces better results than either approach alone. Your prescriber will discuss how to integrate simeigelutai into a comprehensive weight management plan.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.